Literature DB >> 15557215

Pattern of expression of HtrA1 during mouse development.

Antonio De Luca1, Maria De Falco, Luca De Luca, Roberta Penta, Viji Shridhar, Feliciano Baldi, Mara Campioni, Marco G Paggi, Alfonso Baldi.   

Abstract

The human HtrA family of proteases consists of four members: HtrA1, HtrA2, HtrA3, and HtrA4. In humans the four HtrA homologues appear to be involved in several important functions such as cell growth, apoptosis, and inflammatory reactions, and they control cell fate via regulated protein metabolism. In previous studies it was shown that the expression of HtrA1 was ubiquitous in normal adult human tissues. Here we examined the expression of HtrA1 protein and its corresponding mRNA during mouse embryogenesis using Northern blotting hybridization, RT-PCR, and immunohistochemical staining analyses. Our results indicate that HtrA1 is expressed in a variety of tissues in mouse embryos. Furthermore, this expression is regulated in a spatial and temporal manner. Relatively low levels of HtrA1 mRNA are detected in embryos at the beginning of organogenesis (E8), and the levels of expression increase during late organogenesis (E14-E19). Our results show that HtrA1 was expressed during embryonic development in specific areas where signaling by TGFbeta family proteins plays important regulatory roles. The expression of HtrA1, documented both at mRNA and protein levels by RT-PCR and immunohistochemistry in the developing nervous system, is consistent with a possible role of this protein both in dividing and postmitotic neurons, possibly via its documented inhibitory effects on TGFbeta proteins. An exhaustive knowledge of the different cell- and tissue-specific patterns of expression of HtrA1 in normal mouse embryos is essential for a critical evaluation of the exact role played by this protein during development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557215     DOI: 10.1369/jhc.4A6330.2004

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  16 in total

1.  Susceptibility genes for age-related maculopathy on chromosome 10q26.

Authors:  Johanna Jakobsdottir; Yvette P Conley; Daniel E Weeks; Tammy S Mah; Robert E Ferrell; Michael B Gorin
Journal:  Am J Hum Genet       Date:  2005-07-26       Impact factor: 11.025

2.  Risk- and non-risk-associated variants at the 10q26 AMD locus influence ARMS2 mRNA expression but exclude pathogenic effects due to protein deficiency.

Authors:  Ulrike Friedrich; Connie A Myers; Lars G Fritsche; Andrea Milenkovich; Armin Wolf; Joseph C Corbo; Bernhard H F Weber
Journal:  Hum Mol Genet       Date:  2011-01-20       Impact factor: 6.150

3.  Implications of the serine protease HtrA1 in amyloid precursor protein processing.

Authors:  Sandra Grau; Alfonso Baldi; Rossana Bussani; Xiaodan Tian; Raluca Stefanescu; Michael Przybylski; Peter Richards; Simon A Jones; Viji Shridhar; Tim Clausen; Michael Ehrmann
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-26       Impact factor: 11.205

4.  Elevated serine protease HtrA1 inhibits cell proliferation, reduces invasion, and induces apoptosis in esophageal squamous cell carcinoma by blocking the nuclear factor-κB signaling pathway.

Authors:  Jin Xia; Feng Wang; Liuxing Wang; Qingxia Fan
Journal:  Tumour Biol       Date:  2012-10-19

5.  Age-related macular degeneration-associated silent polymorphisms in HtrA1 impair its ability to antagonize insulin-like growth factor 1.

Authors:  Sarah Melissa P Jacobo; Margaret M Deangelis; Ivana K Kim; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2013-03-11       Impact factor: 4.272

6.  Human HtrA1 in the archived eyes with age-related macular degeneration.

Authors:  Chi-Chao Chan; Defen Shen; Min Zhou; Robert J Ross; Xiaoyan Ding; Kang Zhang; W Richard Green; Jingsheng Tuo
Journal:  Trans Am Ophthalmol Soc       Date:  2007

7.  Expression and localization of serine protease Htra1 in neuroblastoma: correlation with cellular differentiation grade.

Authors:  Velia D'Angelo; Giulia Pecoraro; Paolo Indolfi; Adriana Iannotta; Vittoria Donofrio; Maria Elena Errico; Cristiana Indolfi; Maria Ramaglia; Angela Lombardi; Martina Di Martino; Vincenzo Gigantino; Alfonso Baldi; Michele Caraglia; Antonio De Luca; Fiorina Casale
Journal:  J Neurooncol       Date:  2014-02-04       Impact factor: 4.130

8.  The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples.

Authors:  Jingsheng Tuo; Robert J Ross; George F Reed; Qing Yan; Jie Jin Wang; Christine M Bojanowski; Emily Y Chew; Xiao Feng; Timothy W Olsen; Frederick L Ferris; Paul Mitchell; Chi-Chao Chan
Journal:  Ophthalmology       Date:  2008-08-21       Impact factor: 12.079

9.  The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis.

Authors:  Sonia Sanz Muñoz; Hongyun Li; Kalani Ruberu; Qian Chu; Alan Saghatelian; Lezanne Ooi; Brett Garner
Journal:  J Biol Chem       Date:  2018-02-02       Impact factor: 5.157

10.  Pharmacogenetic influence of LOC387715/HTRA1 on the efficacy of bevacizumab treatment for age-related macular degeneration in a Korean population.

Authors:  Haeng Ku Kang; Myung Hun Yoon; Dae Hyun Lee; Hee Seung Chin
Journal:  Korean J Ophthalmol       Date:  2012-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.